Neo/adjuvant chemotherapy does not improve outcome in resected primary synovial sarcoma: a study of the French Sarcoma Group. (Q34602033)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19088169%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

title

Neo/adjuvant chemotherapy does not improve outcome in resected primary synovial sarcoma: a study of the French Sarcoma Group (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19088169%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19088169%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Yves-Marie Robin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19088169%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Jean-Yves Blay

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19088169%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

7

M Tubiana-Hulin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19088169%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

A Italiano

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19088169%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

B Bui

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19088169%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

S Piperno-Neumann

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19088169%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

E Bompas

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19088169%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

C Chevreau

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19088169%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

N Isambert

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19088169%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

S Leyvraz

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19088169%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

P P du Chatelard

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19088169%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

A Thyss

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19088169%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

J-M Coindre

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19088169%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

A Le Cesne

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19088169%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

publication date

16 December 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19088169%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19088169%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19088169%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19088169%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

425-430

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19088169%20AND%20SRC:MED&resulttype=core&format=json

The reason for confining the use of adjuvant chemotherapy in soft tissue sarcoma to the investigational setting

18 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN678

Randomized clinical trials in soft tissue sarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN678

A randomised phase II study on neo-adjuvant chemotherapy for 'high-risk' adult soft-tissue sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN678

Synovial sarcoma of childhood and adolescence: a multicenter, multivariate analysis of outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN678

Chemotherapy is associated with improved survival in adult patients with primary extremity synovial sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN678

Histologic grade, but not SYT-SSX fusion type, is an important prognostic factor in patients with synovial sarcoma: a multicenter, retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN678

How to calculate the dose of chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN678

Prognostic factors in advanced synovial sarcoma: an analysis of 104 patients treated at the Royal Marsden Hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN678